Loading...
•
Jun 27, 2020
Thermo Fisher Q2 2020 Earnings Report
Thermo Fisher Scientific reported an extraordinary quarter, leveraging its scale and expertise to meet strong global demand for COVID-19 products and services.
Key Takeaways
Thermo Fisher Scientific's second quarter revenue increased by 10% to $6.92 billion, driven by strong demand for COVID-19 related products and services. Adjusted EPS increased 28% to $3.89.
Second quarter revenue increased 10% to $6.92 billion.
Second quarter GAAP diluted earnings per share (EPS) increased 5% to $2.90.
Second quarter adjusted EPS increased 28% to $3.89.
Generated approximately $1.3 billion of COVID-related revenue.
Revenue by Segment
Forward Guidance
Thermo Fisher Scientific did not provide GAAP financial measures on a forward-looking basis because they are unable to predict with reasonable certainty and without unreasonable effort items such as the timing and amount of future restructuring actions and acquisition-related charges as well as gains or losses from sales of real estate and businesses, the early retirement of debt and the outcome of legal proceedings.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...